| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Otolaryngology-Head and Neck Surgery [G. C. B., W. K., D. S.], Surgery [G. C. B.], and Pathology [W. H. W.], Johns Hopkins Hospital, Baltimore, Maryland 21205-2195, and Department of Pathology, Johns Hopkins Hospital Bayview Medical Center, Baltimore, Maryland 21224 [E. G.]
Patients with head and neck cancers have a high (23%/year) incidence of second primary lesions. Clinically, these new lesions are identified either simultaneously with the primary lesion (synchronous) or after a period of time (metachronous). This observation has been attributed to the concept of "field carcinogenesis," which is based on the hypothesis that prolonged exposure to carcinogens leads to the independent transformation of multiple epithelial cells at several sites. An alternative theory is based on the premise that any transforming event is rare; following initial transformation, the progeny of the transformed clone spread through the mucosa and give rise to geographically distinct but genetically related tumors. We analyzed the pattern of X-chromosome inactivation in multiple primary tumors from eight female patients with head and neck cancer. In addition, we used microsatellite analysis to examine the pattern of allelic loss on chromosomes 9p and 3p, identified as early events in the progression of head and neck malignancies. In four of four cases, multiple tumors demonstrated the same pattern of X-chromosome inactivation. In the remaining four cases, X-chromosome deletions prevented interpretation (n = 3), or the androgen receptor locus was noninformative (n = 1). In three of nine patients, multiple tumors displayed the same pattern of loss of heterozygosity, two with identical breakpoints on chromosome 9p. In one patient, there was an identical microsatellite alteration at a 3p locus, definitive evidence that these tumors arose from the same clone. Our findings suggest that in at least a proportion of patients with head and neck cancers, multiple primary tumors arise from a single clone.
1 Supported by Lung Cancer Specialized Program of Research Excellence (SPORE) Grant CA-58184-01.
2 To whom requests for reprints should be addressed, at Head and Neck Cancer Research Division, 818 Ross Research Building, 720 Rutland Avenue, Baltimore, MD 21205-2195.
Received 2/29/96. Accepted 4/11/96.
This article has been cited by other articles:
![]() |
W. H. Westra, J. M. Taube, M.L. Poeta, S. Begum, D. Sidransky, and W. M. Koch Inverse Relationship between Human Papillomavirus-16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., January 15, 2008; 14(2): 366 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy J. Dent. Res., January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Franzmann, E. P. Reategui, F. Pedroso, F. G. Pernas, B. M. Karakullukcu, K. L. Carraway, K. Hamilton, R. Singal, and W. J. Goodwin Soluble CD44 Is a Potential Marker for the Early Detection of Head and Neck Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1348 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kishino, H Shibuya, R Yoshimura, S M Miura, and H Watanabe A retrospective analysis of the use of brachytherapy in relation to early stage squamous cell carcinoma of the oropharynx and its relationship to second primary respiratory and upper digestive tract cancers Br. J. Radiol., February 1, 2007; 80(950): 121 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, J. Gu, Q. Dong, M. Huang, K.-A. Do, W. K. Hong, and M. R. Spitz Joint Effect of Mutagen Sensitivity and Insulin-Like Growth Factors in Predicting the Risk of Developing Secondary Primary Tumors and Tumor Recurrence in Patients with Head and Neck Cancer Clin. Cancer Res., December 1, 2006; 12(23): 7194 - 7201. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Westra and D. Sidransky Fluorescence Visualization in Oral Neoplasia: Shedding Light on an Old Problem. Clin. Cancer Res., November 15, 2006; 12(22): 6594 - 6597. [Full Text] [PDF] |
||||
![]() |
K. D. Hunter, J. K. Thurlow, J. Fleming, P. J.H. Drake, J. K. Vass, G. Kalna, D. J. Higham, P. Herzyk, D. G. MacDonald, E. K. Parkinson, et al. Divergent routes to oral cancer. Cancer Res., August 1, 2006; 66(15): 7405 - 7413. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Perez-Ordonez, M Beauchemin, and R C K Jordan Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol., May 1, 2006; 59(5): 445 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman and J. J. Lee Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res., March 15, 2006; 66(6): 2893 - 2903. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Begum, D. Cao, M. Gillison, M. Zahurak, and W. H. Westra Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma Clin. Cancer Res., August 15, 2005; 11(16): 5694 - 5699. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J.M. Braakhuis, R. H. Brakenhoff, and C. R. Leemans Second Field Tumors: A New Opportunity for Cancer Prevention? Oncologist, August 1, 2005; 10(7): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Maley, P. C. Galipeau, X. Li, C. A. Sanchez, T. G. Paulson, and B. J. Reid Selectively Advantageous Mutations and Hitchhikers in Neoplasms: p16 Lesions Are Selected in Barrett's Esophagus Cancer Res., May 15, 2004; 64(10): 3414 - 3427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sudbo, S. M. Lippman, J. J. Lee, L. Mao, W. Kildal, A. Sudbo, S. Sagen, M. Bryne, A. El-Naggar, B. Risberg, et al. The Influence of Resection and Aneuploidy on Mortality in Oral Leukoplakia N. Engl. J. Med., April 1, 2004; 350(14): 1405 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rudin, E. E.W. Cohen, V. A. Papadimitrakopoulou, S. Silverman Jr, W. Recant, A. K. El-Naggar, K. Stenson, S. M. Lippman, W. K. Hong, and E. E. Vokes An Attenuated Adenovirus, ONYX-015, As Mouthwash Therapy for Premalignant Oral Dysplasia J. Clin. Oncol., December 15, 2003; 21(24): 4546 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Ha and J. A. Califano THE MOLECULAR BIOLOGY OF MUCOSAL FIELD CANCERIZATION OF THE HEAD AND NECK Crit. Rev. Oral. Biol. Med., September 1, 2003; 14(5): 363 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. M. Braakhuis, M. P. Tabor, J. A. Kummer, C. R. Leemans, and R. H. Brakenhoff A Genetic Explanation of Slaughter's Concept of Field Cancerization: Evidence and Clinical Implications Cancer Res., April 15, 2003; 63(8): 1727 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Tabor, R. H. Brakenhoff, H. J. Ruijter-Schippers, J. E. van der Wal, G. B. Snow, C. R. Leemans, and B. J. M. Braakhuis Multiple Head and Neck Tumors Frequently Originate from a Single Preneoplastic Lesion Am. J. Pathol., September 1, 2002; 161(3): 1051 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mao A New Marker Determining Clonal Outgrowth Clin. Cancer Res., July 1, 2002; 8(7): 2021 - 2023. [Full Text] [PDF] |
||||
![]() |
P. K. Ha, B. C. Tong, W. H. Westra, M. Sanchez-Cespedes, P. Parrella, M. Zahurak, D. Sidransky, and J. A Califano Mitochondrial C-tract Alteration in Premalignant Lesions of the Head and Neck: A Marker for Progression and Clonal Proliferation Clin. Cancer Res., July 1, 2002; 8(7): 2260 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Wax, L. L. Myers, E. C. Gabalski, S. Husain, J. M. Gona, and H. Nabi Positron Emission Tomography in the Evaluation of Synchronous Lung Lesions in Patients With Untreated Head and Neck Cancer Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 703 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and Neck Cancer N. Engl. J. Med., December 27, 2001; 345(26): 1890 - 1900. [Full Text] [PDF] |
||||
![]() |
A. K. El-Naggar, L. Mao, G. Staerkel, M. M. Coombes, S. L. Tucker, M. A. Luna, G. L. Clayman, S. Lippman, and H. Goepfert Genetic Heterogeneity in Saliva from Patients with Oral Squamous Carcinomas: Implications in Molecular Diagnosis and Screening J. Mol. Diagn., November 1, 2001; 3(4): 164 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Khuri, E. S. Kim, J. J. Lee, R. J. Winn, S. E. Benner, S. M. Lippman, K. K. Fu, J. S. Cooper, E. E. Vokes, R. M. Chamberlain, et al. The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Partridge, S. Pateromichelakis, E. Phillips, G. Emilion, and J. Langdon Profiling Clonality and Progression in Multiple Premalignant and Malignant Oral Lesions Identifies a Subgroup of Cases with a Distinct Presentation of Squamous Cell Carcinoma Clin. Cancer Res., July 1, 2001; 7(7): 1860 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, K. Yamaguchi, M. Sanchez-Cespedes, W. H. Westra, W. M. Koch, and D. Sidransky Allelic Losses in OraTest-directed Biopsies of Patients with Prior Upper Aerodigestive Tract Malignancy Clin. Cancer Res., July 1, 2001; 7(7): 1963 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Tabor, R. H. Brakenhoff, V. M. M. van Houten, J. A. Kummer, M. H. J. Snel, P. J. F. Snijders, G. B. Snow, C. R. Leemans, and B. J. M. Braakhuis Persistence of Genetically Altered Fields in Head and Neck Cancer Patients: Biological and Clinical Implications Clin. Cancer Res., June 1, 2001; 7(6): 1523 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sudbo, W. Kildal, B. Risberg, H. S. Koppang, H. E. Danielsen, and A. Reith DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia N. Engl. J. Med., April 26, 2001; 344(17): 1270 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rubin Selected Cell and Selective Microenvironment in Neoplastic Development Cancer Res., February 1, 2001; 61(3): 799 - 807. [Abstract] [Full Text] |
||||
![]() |
M. Chow and H. Rubin Clonal Selection versus Genetic Instability as the Driving Force in Neoplastic Transformation Cancer Res., November 1, 2000; 60(22): 6510 - 6518. [Abstract] [Full Text] |
||||
![]() |
J. Cloos, C. R. Leemans, M. L. T. van der Sterre, D. J. Kuik, G. B. Snow, and B. J. M. Braakhuis Mutagen Sensitivity as a Biomarker for Second Primary Tumors after Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 713 - 717. [Abstract] [Full Text] |
||||
![]() |
C. R. Antonescu, A. Elahi, J. H. Healey, M. F. Brennan, M. Y. Lui, J. Lewis, S. C. Jhanwar, J. M. Woodruff, and M. Ladanyi Monoclonality of Multifocal Myxoid Liposarcoma: Confirmation by Analysis of TLS-CHOP or EWS-CHOP Rearrangements Clin. Cancer Res., July 1, 2000; 6(7): 2788 - 2793. [Abstract] [Full Text] |
||||
![]() |
M. G. C. T. van Oijen and P. J. Slootweg Oral Field Cancerization: Carcinogen-induced Independent Events or Micrometastatic Deposits? Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 249 - 256. [Abstract] [Full Text] |
||||
![]() |
J. Califano, W. H. Westra, G. Meininger, R. Corio, W. M. Koch, and D. Sidransky Genetic Progression and Clonal Relationship of Recurrent Premalignant Head and Neck Lesions Clin. Cancer Res., February 1, 2000; 6(2): 347 - 352. [Abstract] [Full Text] |
||||
![]() |
M. P. Rosin, X. Cheng, C. Poh, W. L. Lam, Y. Huang, J. Lovas, K. Berean, J. B. Epstein, R. Priddy, N. D. Le, et al. Use of Allelic Loss to Predict Malignant Risk for Low-grade Oral Epithelial Dysplasia Clin. Cancer Res., February 1, 2000; 6(2): 357 - 362. [Abstract] [Full Text] |
||||
![]() |
M. Chow and H. Rubin Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones PNAS, January 4, 2000; 97(1): 174 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Califano, W. Koch, D. Sidransky, and W. H. Westra Inverted Sinonasal Papilloma : A Molecular Genetic Appraisal of Its Putative Status as aPrecursor to Squamous Cell Carcinoma Am. J. Pathol., January 1, 2000; 156(1): 333 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Stafford, J. N. E. Ashman, A. W. MacDonald, S. R. Ell, J. R. T. Monson, and J. Greenman Genetic Analysis of Head and Neck Squamous Cell Carcinoma and Surrounding Mucosa Arch Otolaryngol Head Neck Surg, December 1, 1999; 125(12): 1341 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kopelovich, D. E. Henson, A. F. Gazdar, B. Dunn, S. Srivastava, G. J. Kelloff, and P. Greenwald Surrogate Anatomic/Functional Sites for Evaluating Cancer Risk: An Extension of the Field Effect Clin. Cancer Res., December 1, 1999; 5(12): 3899 - 3905. [Full Text] [PDF] |
||||
![]() |
L. J. Prevo, C. A. Sanchez, P. C. Galipeau, and B. J. Reid p53-Mutant Clones and Field Effects in Barrett's Esophagus Cancer Res., October 1, 1999; 59(19): 4784 - 4787. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Califano, P. L. Leong, W. M. Koch, C. F. Eisenberger, D. Sidransky, and W. H. Westra Second Esophageal Tumors in Patients with Head and Neck Squamous Cell Carcinoma: An Assessment of Clonal Relationships Clin. Cancer Res., July 1, 1999; 5(7): 1862 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chow and H. Rubin Clonal dynamics of progressive neoplastic transformation PNAS, June 8, 1999; 96(12): 6976 - 6981. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Califano, W. H. Westra, W. Koch, G. Meininger, A. Reed, L. Yip, J. O. Boyle, F. Lonardo, and D. Sidransky Unknown Primary Head and Neck Squamous Cell Carcinoma: Molecular Identification of the Site of Origin J Natl Cancer Inst, April 7, 1999; 91(7): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chow and H. Rubin The cellular ecology of progressive neoplastic transformation: A clonal analysis PNAS, March 2, 1999; 96(5): 2093 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Weber, M. Scheer, I. A. Born, S. Joos, J. M. J. L. Cobbers, C. Hofele, G. Reifenberger, J. E. Zoller, and P. Lichter Recurrent Chromosomal Imbalances Detected in Biopsy Material from Oral Premalignant and Malignant Lesions by Combined Tissue Microdissection, Universal DNA Amplification, and Comparative Genomic Hybridization Am. J. Pathol., July 1, 1998; 153(1): 295 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamada, A. T. De Souza, S. Finkelstein, and R. L. Jirtle Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis PNAS, September 16, 1997; 94(19): 10351 - 10355. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |